Minimally Invasive Surgery in Florida

PLU Ophthalmic is a US-based medical device company developing next-generation glaucoma surgical technology. The company focuses on advanced glaucoma care solutions that bridge the current clinical gap between traditional high-efficacy but high-risk procedures (trabeculectomy) and minimally invasive glaucoma surgery (MIGS) techniques that offer superior safety but limited efficacy. PLU Ophthalmic's proprietary technology employs precise micro-excision methodology to deliver implant-free glaucoma surgery with superior intraocular pressure reduction, enhanced safety profile, and minimal learning curve compared to existing MIGS platforms. The technology addresses a significant clinical need: glaucoma is the second leading cause of blindness globally, affecting approximately 80,000 people worldwide with 3 million cases in the US and a projected economic burden of $12 billion by 2032 and $17.3 billion by 2050. The company's solution targets ophthalmologists and glaucoma specialists seeking to improve surgical efficacy while reducing procedural risk and post-operative complications. PLU Ophthalmic emphasizes simplified patient management, enhanced patient outcomes, and improved OR productivity through shorter surgical times and reduced post-operative care requirements. The platform is designed to outperform current MIGS offerings while maintaining a safety advantage over traditional trabeculectomy, positioning it as a transformative approach in glaucoma surgical care.

FAGA Medical is a Brazilian manufacturer of medical-surgical equipment and instruments specializing in lipoaspirative and cosmetic surgical solutions. The company develops and manufactures electromedical equipment, reusable surgical instruments, and disposable consumables with a focus on precision, safety, and cost-effectiveness. Core product lines include vibratory liposuction systems (VIBROFIT®), ultrasonic-assisted fat extraction equipment (SAFER), surgical irrigators (INFlow), surgical cannulas manufactured from 316L stainless steel, fat transfer devices, and surgical support materials including drainage systems, collection bottles, and specialized surgical kits. Products are designed in partnership with clinical professionals to address real-world surgical needs. FAGA Medical maintains strategic partnerships with technology partners in Germany, Switzerland, France, and the United States. The company holds certifications including ANVISA (Brazilian regulatory approval), FDA, ISO 9001, and ISO 13485, demonstrating compliance with international quality and medical device standards. Manufacturing encompasses equipment design, precision instrumentation, sterilization-compatible materials, and quality control throughout production. The company serves surgical centers, hospitals, and cosmetic medical practices with emphasis on ergonomics, durability, and procedural efficiency.

TAS Medical, Inc. is a surgical device manufacturer specializing in soft tissue approximation and abdominal wall closure solutions. The company has developed the ZipStrap system, a surgical-grade device designed to facilitate soft tissue approximation across open, laparoscopic, and robotic surgical procedures in general surgery. The ZipStrap represents an innovation in wound closure and tissue approximation technology, offering surgeons an alternative approach to traditional closure methods. The company serves the general surgery market, including surgeons performing open, minimally invasive laparoscopic, and robotic-assisted procedures. TAS Medical is based in Windermere, Florida. The company website indicates regulatory clearance documentation is available via their Instruction for Use (IFU) page, suggesting FDA or equivalent regulatory approval for the ZipStrap device. The organization engages with multiple stakeholder groups including physicians, advanced practice providers, healthcare administrators, and industry representatives.

Focalyx is a MedTech company specializing in precision diagnosis and treatment of prostate cancer through AI-driven software and minimally invasive procedural guidance. The Focalyx Fusion platform provides computer-assisted surgical planning and real-time intraoperative guidance for focal prostate therapy, enabling targeted ablation of cancerous lesions while preserving healthy prostate tissue and function. The platform combines advanced imaging analysis with GPS-like navigation to deliver office-based, outpatient prostate cancer treatment with minimal hospitalization, fast recovery, and improved preservation of urinary and sexual function. Clinical outcomes demonstrate 86% cancer-free status at 5 years with 95% urinary improvement and 88% erectile retention rates across 6,000+ procedures performed globally.

SurGenTec is a privately held medical device manufacturer specializing in minimally invasive orthopedic and neurosurgical spine solutions. The company develops and markets a comprehensive portfolio of bone graft delivery systems, synthetic biologics, sacroiliac joint fusion implants, and spine stabilization hardware. Core product lines include the GraftGun® precision delivery system, OsteoFlo® bone void fillers (HydroFiber, HydroPutty, NanoPutty), TILINK® SI joint and lateral fusion systems, ION-C™ cervical stabilization, ALARA® Access Needle, and Ossify® cortical fiber grafts. SurGenTec's devices feature advanced surface technologies and are FDA-cleared for use across cervical, thoracic, and lumbar spine applications, including trauma, tumor, osteomyelitis, and degenerative indications. The company serves both domestic and international surgical markets through direct sales and distributor partnerships.

Praxis Medical LLC is a medical device company headquartered in Tampa, Florida, specializing in motorized, rotating fine needle biopsy systems. The company develops innovative, minimally invasive biopsy devices designed to improve diagnostic outcomes in soft tissue and pulmonary sampling. Their primary product lines include CytoCore, a percutaneous soft tissue biopsy system for radiology applications, and EndoCore, an endobronchial ultrasound (EBUS)-guided biopsy device for pulmonology. Both systems utilize proprietary rotary needle technology that enables collection of core-comparable tissue samples in fewer needle passes compared to standard fine needle aspiration (FNA) techniques. The devices employ non-firing needle mechanisms to prioritize patient safety while maintaining high specimen quality for diagnosis and disease staging. Praxis Medical targets interventional radiologists, pulmonologists, and diagnostic specialists in hospital and outpatient surgical settings. The company emphasizes minimally invasive approaches, reduced procedural passes, improved diagnostic yield, and enhanced patient outcomes as key differentiators. Manufacturing and regulatory status information is not detailed on the website; clinical validation and regulatory pathway details are not explicitly stated.

Biorep Technologies is an ISO 13485-certified, FDA-registered medical device contract design and manufacturing organization (CDMO) based in Miami Lakes, Florida. Founded in 1994, the company specializes in end-to-end medical device development and manufacturing services, including rapid prototyping, design verification, process development and validation, contract manufacturing, and assembly services. With over 30 years of experience, Biorep serves medical device companies across cardiovascular, minimally invasive surgical instruments, ENT devices, and diabetes research equipment sectors. The company maintains a vertically integrated structure with capabilities spanning concept through scale-up, production launch, and lifecycle support. Biorep partners with global med-tech innovators and maintains a strategic partnership with the Diabetes Research Institute, providing essential research equipment for type I diabetes initiatives. The company operates with documented design controls, traceability systems, supply chain management, and regulatory compliance infrastructure compatible with US, EU, and Asian markets.

Vycor Medical, Inc. operates two distinct business units specializing in neurosurgical and neurotherapeutic solutions. The primary division designs and manufactures neurosurgical medical devices, with the ViewSite Brain Access System (VBAS) as the flagship product—a minimally invasive neurosurgical device that improves access to brain lesions while reducing tissue damage. Clinical evidence from over 50 studies demonstrates VBAS results in reduced brain tissue trauma, minimized invasiveness, improved surgical visibility, and shortened operating and recovery times. The company's secondary business unit, NovaVision, develops non-invasive, computer-based vision rehabilitation therapies for patients with vision loss resulting from neurological trauma such as stroke. NovaVision Visual Restoration Therapy (VRT) is the only FDA-cleared therapy for vision rehabilitation following neurological brain damage; it is complemented by the NeuroEyeCoach program, which trains patients to make improved eye movements to enhance visual field detection. Vycor Medical serves neurosurgeons, neurologists, rehabilitation specialists, and vision care providers across hospital and outpatient settings. The company holds FDA regulatory clearance for its therapeutic products and demonstrates commitment to clinical validation and evidence-based outcomes.

NovApproach Spine develops innovative solutions for anterior lumbar interbody fusion (ALIF) surgery, specifically designed to simplify surgical approaches and improve patient outcomes. The company's flagship product is the OneLIF™ cage system, a patented interbody implant engineered for single-position anterior lumbar spine surgery. The OneLIF device features a unique design allowing trials and implants to be inserted in both straight and oblique directions with lateral screw fixation from the left side, minimizing soft tissue retraction and vascular exposure compared to traditional ALIF approaches. The system is designed to accommodate a wide range of anatomies while reducing the need for extensive surgical exposure. NovApproach Spine collaborates with leading academic spine surgeons and spinal access surgeons to develop both surgical approaches and corresponding implants that represent advances in lumbar implant versatility. The company emphasizes efficiency, versatility, and surgeon collaboration as core differentiators. Products are marketed toward spine specialists, neurosurgeons, and orthopedic surgeons performing anterior lumbar reconstruction procedures. The technology is positioned as addressing key limitations of traditional ALIF techniques, particularly for cases with limited exposure or complex vascular/neural anatomy. While specific FDA clearance or regulatory credentials are not detailed on the fetched site, the company's focus on surgical innovation and implant design suggests compliance with orthopedic device regulations.

SpineNet is a manufacturer and solutions provider specializing in spinal fusion devices and orthopedic implants. The company offers a comprehensive portfolio of state-of-the-art anterior cervical fusion systems, including the SpineNet SSP (Single-Screw Plate) System and SpineNet ACC (Anterior Cervical Cage) System, both FDA 510(k) cleared. SpineNet's implants are designed to address cervical spine pathology through minimally invasive techniques, featuring advanced materials such as PEEK and leveraging tri-cortical iliac crest bone graft technology. The company partners with surgeon champions and industry leaders to deliver high-quality medical implants with elite service and clinical support. SpineNet serves the orthopedic surgical and neurosurgical community through direct relationships with surgeons and distributor networks.

Miami Fat Supply manufactures and supplies specialized fat harvesting, grafting, and transfer instrumentation for cosmetic and reconstructive surgical procedures. The company's flagship product, the Red Head system, is a large-volume closed-system fat harvesting device designed to protect and preserve adipose tissue for consistent patient outcomes. Miami Fat Supply distributes a comprehensive range of cannulas, handles, adapters, and accessories used by physicians and hospitals nationwide for autologous fat transfer procedures. Product lines include large and small-volume harvesting canisters, injection and infiltration cannulas with multiple port configurations, liposuction instruments, fat transfer adapters, and specialized harvesting accessories. The company emphasizes rapid fulfillment (24/7 ordering, next-business-day shipping) and safe payment processing.

Joline Medical Inc. is the North American distribution subsidiary of Joline GmbH & Co. KG (Germany), specializing in minimally invasive kyphoplasty solutions for vertebral compression fractures. Founded in 1999, Joline designs and manufactures high-precision kyphoplasty systems, including the Stop'n GO Double Balloon system, for treatment of osteoporotic and traumatic vertebral fractures. All products are developed and hand-assembled in Germany under strict quality controls and meet FDA and European regulatory standards. Joline serves hospitals, outpatient surgery centers, and specialty spine clinics, offering clinical education, anatomical training workshops, and dedicated U.S. support. The company emphasizes precision engineering, reliable performance, and patient outcome focus in restoring vertebral height and reducing pain.

Nutek Orthopaedics manufactures advanced minimally-invasive external fixation systems for orthopedic surgery, leveraging over 50 years of surgeon-informed design experience. Their proprietary technology features axial freedom for precision K-wire placement, spherical pin-locking mechanisms, and radiolucent Ultem® plates enabling real-time fluoroscopic visualization. Products address shoulder, wrist, hand, and general orthopedic trauma applications. The systems prioritize reduced operative time, low infection rates, preserved vascularity, minimal soft-tissue damage, and early patient mobility without permanent implants—enabling rapid return to normal function.

New Wave Endo develops innovative surgical technologies designed to improve surgical outcomes, reduce complications, and decrease postoperative pain while reducing opioid dependence. The company's core team previously developed the D-HELP laparoscopic defogging device (now Clearify™ by Medtronic), which has been used in millions of procedures. Their flagship product, the M-Close Kit, addresses port site closure and hernia prevention in minimally invasive surgery, with particular focus on challenging anatomies such as obese patients. The solution provides targeted fascial plane closure technology and fascial plane targeting capabilities. New Wave Endo's technologies support opioid-free recovery protocols and enhance safety in laparoscopic and minimally invasive surgical procedures across major healthcare systems.

Atlas Spine Inc. designs, manufactures, and markets minimally invasive implants and instrument systems for the treatment of spinal pathologies. The company specializes in innovative spine implant technology, with a focus on height and lordosis restoration. Atlas has established itself as a design resource for spine surgeons and major medical device manufacturers. The company develops disruptive technologies for spine care, working closely with leading spine surgeons to create cost-effective, high-quality, and clinically efficacious systems. Their product portfolio includes expandable implant technology such as HiJak AC (Anterior Cervical), designed for superior height and lordosis restoration, particularly at the cervicothoracic junction. The HiJak system enables surgeons to improve patient chin-brow angle outcomes compared to traditional non-expandable implant technology. Atlas serves hospitals and surgical centers requiring advanced minimally invasive spine solutions.